Skip to main content

Advertisement

Log in

Incidence, time trends and survival patterns of childhood pilocytic astrocytomas in Southern-Eastern Europe and SEER, US

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Pilocytic astrocytomas (PA) comprise the most common childhood central nervous system (CNS) tumor. Exploiting registry-based data from Southern and Eastern Europe (SEE) and SEER, US, we opted to examine incidence, time trends, survival and tentative outcome disparities of childhood PA by sociodemographic and clinical features. Childhood PA were retrieved from 12 SEE registries (N = 552; 1983–2014) and SEER (N = 2723; 1973–2012). Age-standardized incidence rates (ASR) were estimated and survival was examined via Kaplan–Meier and Cox regression analysis. ASR of childhood PA during 1990–2012 in SEE was 4.2/106, doubling in the USA (8.2/106). Increasing trends, more prominent during earlier registration years, were recorded in both areas (SEE: +4.1 %, USA: +4.6 %, annually). Cerebellum comprised the most common location, apart from infants in whom supratentorial locations prevailed. Age at diagnosis was 1 year earlier in SEE, whereas 10-year survival was 87 % in SEE and 96 % in SEER, improving over time. Significant outcome predictors were age <1 year at diagnosis diagnosis (hazard ratio, HR [95% confidence intervals]: 3.96, [2.28–6.90]), female gender (HR: 1.38, [1.01–1.88]), residence in SEE (HR: 4.07, [2.95–5.61]) and rural areas (HR: 2.23, [1.53–3.27]), whereas non-cerebellar locations were associated with a 9- to 12-fold increase in risk of death. The first comprehensive overview of childhood PA epidemiology showed survival gains but also outcome discrepancies by geographical region and urbanization pointing to healthcare inequalities. The worse prognosis of infants and, possibly, females merits further consideration, as it might point to treatment adjustment needs, whereas expansion of systematic registration will allow interpretation of incidence variations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Collins VP, Jones DT, Giannini C (2015) Pilocytic astrocytoma: pathology, molecular mechanisms and markers. Acta Neuropathol 129:775–788. doi:10.1007/s00401-015-1410-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 16(Suppl 4):iv1–i63. doi:10.1093/neuonc/nou223

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64:479–489

    Article  CAS  PubMed  Google Scholar 

  4. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin D, Whelan S (2013) International classification of diseases for oncology, third edition, first revision. World Health Organization, Geneva

    Google Scholar 

  5. Burkhard C, Di Patre PL, Schuler D, Schuler G, Yasargil MG, Yonekawa Y, Lutolf UM, Kleihues P, Ohgaki H (2003) A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma. J Neurosurg 98:1170–1174. doi:10.3171/jns.2003.98.6.1170

    Article  PubMed  Google Scholar 

  6. Arora RS, Alston RD, Eden TO, Estlin EJ, Moran A, Birch JM (2009) Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England. Neuro Oncol 11:403–413. doi:10.1215/15228517-2008-097

    Article  PubMed  PubMed Central  Google Scholar 

  7. Jukich PJ, McCarthy BJ, Surawicz TS, Freels S, Davis FG (2001) Trends in incidence of primary brain tumors in the United States, 1985–1994. Neuro Oncol 3:141–151

    CAS  PubMed  PubMed Central  Google Scholar 

  8. McKean-Cowdin R, Razavi P, Barrington-Trimis J, Baldwin RT, Asgharzadeh S, Cockburn M, Tihan T, Preston-Martin S (2013) Trends in childhood brain tumor incidence, 1973–2009. J Neurooncol 115:153–160. doi:10.1007/s11060-013-1212-5

    Article  PubMed  PubMed Central  Google Scholar 

  9. Smith MA, Freidlin B, Ries LA, Simon R (1998) Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 90:1269–1277

    Article  CAS  PubMed  Google Scholar 

  10. Peris-Bonet R, Martinez-Garcia C, Lacour B, Petrovich S, Giner-Ripoll B, Navajas A, Steliarova-Foucher E (2006) Childhood central nervous system tumours–incidence and survival in Europe (1978–1997): report from Automated Childhood Cancer Information System project. Eur J Cancer 42:2064–2080. doi:10.1016/j.ejca.2006.05.009

    Article  PubMed  Google Scholar 

  11. Papathoma P, Thomopoulos TP, Karalexi MA, Ryzhov A, Zborovskaya A, Dimitrova N, Zivkovic S, Eser S, Antunes L, Sekerija M, Zagar T, Bastos J, Demetriou A, Cozma R, Coza D, Bouka E, Dessypris N, Kantzanou M, Kanavidis P, Dana H, Hatzipantelis E, Moschovi M, Polychronopoulou S, Pourtsidis A, Stiakaki E, Papakonstantinou E, Oikonomou K, Sgouros S, Vakis A, Zountsas B, Bourgioti C, Kelekis N, Prassopoulos P, Choreftaki T, Papadopoulos S, Stefanaki K, Strantzia K, Cardis E, Steliarova-Foucher E, Petridou ET (2015) Childhood central nervous system tumours: incidence and time trends in 13 Southern and Eastern European cancer registries. Eur J Cancer 51:1444–1455. doi:10.1016/j.ejca.2015.04.014

    Article  PubMed  Google Scholar 

  12. Nejat F, El Khashab M, Rutka JT (2008) Initial management of childhood brain tumors: neurosurgical considerations. J Child Neurol 23:1136–1148. doi:10.1177/0883073808321768

    Article  PubMed  PubMed Central  Google Scholar 

  13. Mathew RK, O’Kane R, Parslow R, Stiller C, Kenny T, Picton S, Chumas PD (2014) Comparison of survival between the UK and US after surgery for most common pediatric CNS tumors. Neuro Oncol 16:1137–1145. doi:10.1093/neuonc/nou056

    Article  PubMed  PubMed Central  Google Scholar 

  14. Colin C, Padovani L, Chappe C, Mercurio S, Scavarda D, Loundou A, Frassineti F, Andre N, Bouvier C, Korshunov A, Lena G, Figarella-Branger D (2013) Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution. Neuropathol Appl Neurobiol 39:693–705. doi:10.1111/nan.12013

    Article  CAS  PubMed  Google Scholar 

  15. Znaor A, van den Hurk C, Primic-Zakelj M, Agius D, Coza D, Demetriou A, Dimitrova N, Eser S, Karakilinc H, Zivkovic S, Bray F, Coebergh JW (2013) Cancer incidence and mortality patterns in South Eastern Europe in the last decade: gaps persist compared with the rest of Europe. Eur J Cancer 49:1683–1691. doi:10.1016/j.ejca.2012.11.030

    Article  PubMed  Google Scholar 

  16. Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B, Orisme W, Punchihewa C, Parker M, Qaddoumi I, Boop FA, Lu C, Kandoth C, Ding L, Lee R, Huether R, Chen X, Hedlund E, Nagahawatte P, Rusch M, Boggs K, Cheng J, Becksfort J, Ma J, Song G, Li Y, Wei L, Wang J, Shurtleff S, Easton J, Zhao D, Fulton RS, Fulton LL, Dooling DJ, Vadodaria B, Mulder HL, Tang C, Ochoa K, Mullighan CG, Gajjar A, Kriwacki R, Sheer D, Gilbertson RJ, Mardis ER, Wilson RK, Downing JR, Baker SJ, Ellison DW, St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project (2013) Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45:602–612 doi:10.1038/ng.2611

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Karalexi MA, Papathoma P, Thomopoulos TP, Ryzhov A, Zborovskaya A, Dimitrova N, Zivkovic S, Eser S, Antunes L, Sekerija M, Zagar T, Bastos J, Demetriou A, Agius D, Cozma R, Coza D, Bouka E, Dessypris N, Belechri M, Dana H, Hatzipantelis E, Papakonstantinou E, Polychronopoulou S, Pourtsidis A, Stiakaki E, Chatziioannou A, Manolitsi K, Orphanidis G, Papadopoulos S, Papathanasiou M, Patsouris E, Sgouros S, Zountsas B, Moschovi M, Steliarova-Foucher E, Petridou ET (2015) Childhood central nervous system tumour mortality and survival in Southern and Eastern Europe (1983–2014): gaps persist across 14 cancer registries. Eur J Cancer 51:2665–2677. doi:10.1016/j.ejca.2015.08.018

    Article  PubMed  Google Scholar 

  18. Surveillance, Epidemiology, End Results (SEER) Program (http://www.seer.cancer.gov) Research data (1973–2012), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission

  19. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin D et al (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva

    Google Scholar 

  20. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P (2005) International classification of childhood cancer, third edition. Cancer 103:1457–1467. doi:10.1002/cncr.20910

    Article  PubMed  Google Scholar 

  21. Bramer GR (1988) International statistical classification of diseases and related health problems. Tenth revision. World Health Stat Q 41:32–36

    CAS  PubMed  Google Scholar 

  22. McDade TW, Adair LS (2001) Defining the “urban” in urbanization and health: a factor analysis approach. Soc Sci Med 53:55–70

    Article  CAS  PubMed  Google Scholar 

  23. Zanetti R, Sera F, Sacchetto L, Coebergh JW, Rosso S (2015) Power analysis to detect time trends on population-based cancer registries data: when size really matters. Eur J Cancer 51:1082–1090. doi:10.1016/j.ejca.2013.10.008

    Article  PubMed  Google Scholar 

  24. Steliarova-Foucher E, Stiller C, Colombet M, Kaatsch P, Zanetti R, Peris-Bonet R (2015) Registration of childhood cancer: moving towards pan-European coverage? Eur J Cancer 51:1064–1079. doi:10.1016/j.ejca.2015.03.009

    Article  PubMed  Google Scholar 

  25. Kaderali Z, Lamberti-Pasculli M, Rutka JT (2009) The changing epidemiology of paediatric brain tumours: a review from the Hospital for Sick Children. Childs Nerv Syst 25:787–793. doi:10.1007/s00381-008-0771-9

    Article  PubMed  Google Scholar 

  26. McNally RJ, Kelsey AM, Cairns DP, Taylor GM, Eden OB, Birch JM (2001) Temporal increases in the incidence of childhood solid tumors seen in Northwest England (1954–1998) are likely to be real. Cancer 92:1967–1976

    Article  CAS  PubMed  Google Scholar 

  27. Reutfors J, Kramarova E, Weiderpass E, Monge P, Wesseling C, Ahlbom A (2002) Central nervous system tumours in children in Costa Rica, 1981–96. Paediatr Perinat Epidemiol 16:219–225

    Article  PubMed  Google Scholar 

  28. Stiller CA, Nectoux J (1994) International incidence of childhood brain and spinal tumours. Int J Epidemiol 23:458–464

    Article  CAS  PubMed  Google Scholar 

  29. Hoffman S, Propp JM, McCarthy BJ (2006) Temporal trends in incidence of primary brain tumors in the United States, 1985–1999. Neuro Oncol 8:27–37. doi:10.1215/S1522851705000323

    Article  PubMed  PubMed Central  Google Scholar 

  30. Patel S, Bhatnagar A, Wear C, Osiro S, Gabriel A, Kimball D, John A, Fields PJ, Tubbs RS, Loukas M (2014) Are pediatric brain tumors on the rise in the USA? Significant incidence and survival findings from the SEER database analysis. Childs Nerv Syst 30:147–154. doi:10.1007/s00381-013-2307-1

    Article  PubMed  Google Scholar 

  31. Dodgshun AJ, Maixner WJ, Hansford JR, Sullivan MJ (2016) Low rates of recurrence and slow progression of pediatric pilocytic astrocytoma after gross-total resection: justification for reducing surveillance imaging. J Neurosurg Pediatr. doi:10.3171/2015.9.PEDS15449

    PubMed  Google Scholar 

  32. Buder T, Deutsch A, Klink B, Voss-Bohme A (2015) Model-based evaluation of spontaneous tumor regression in pilocytic astrocytoma. PLoS Comput Biol 11:e1004662. doi:10.1371/journal.pcbi.1004662

    Article  PubMed  PubMed Central  Google Scholar 

  33. Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour B, Mallone S, Marcos-Gragera R, Minicozzi P, Sanchez-Perez MJ, Sant M, Santaquilani M, Stiller C, Tavilla A, Trama A, Visser O, Peris-Bonet R, EUROCARE Working Group (2014) Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5–a population-based study. Lancet Oncol 15:35–47. doi:10.1016/S1470-2045(13)70548-5

    Article  PubMed  Google Scholar 

  34. Sergentanis T, Dessypris N, Kanavidis P, Skalkidis I, Baka M, Polychronopoulou S, Athanassiadou F, Stiakaki E, Frangandrea I, Moschovi M, Petridou ET (2013) Socioeconomic status, area remoteness, and survival from childhood leukemia: results from the Nationwide Registry for Childhood Hematological Malignancies in Greece. Eur J Cancer Prev 22:473–479. doi:10.1097/CEJ.0b013e32835c7f69

    Article  PubMed  Google Scholar 

  35. Petridou ET, Sergentanis TN, Perlepe C, Papathoma P, Tsilimidos G, Kontogeorgi E, Kourti M, Baka M, Moschovi M, Polychronopoulou S, Sidi V, Hatzipantelis E, Stiakaki E, Iliadou AN, La Vecchia C, Skalkidou A, Adami HO (2015) Socioeconomic disparities in survival from childhood leukemia in the United States and globally: a meta-analysis. Ann Oncol 26:589–597. doi:10.1093/annonc/mdu572

    Article  CAS  PubMed  Google Scholar 

  36. Meilleur A, Subramanian SV, Plascak JJ, Fisher JL, Paskett ED, Lamont EB (2013) Rural residence and cancer outcomes in the United States: issues and challenges. Cancer Epidemiol Biomarkers Prev 22:1657–1667. doi:10.1158/1055-9965.EPI-13-0404

    Article  PubMed  Google Scholar 

  37. Di Rocco C, Ceddia A, Iannelli A (1993) Intracranial tumours in the first year of life. A report on 51 cases. Acta Neurochir (Wien) 123:14–24

    Article  CAS  Google Scholar 

  38. Rickert CH, Probst-Cousin S, Gullotta F (1997) Primary intracranial neoplasms of infancy and early childhood. Childs Nerv Syst 13:507–513. doi:10.1007/s003810050127

    Article  CAS  PubMed  Google Scholar 

  39. Sala F, Colarusso E, Mazza C, Talacchi A, Bricolo A (1999) Brain tumors in children under 3 years of age. Recent experience (1987–1997) in 39 patients. Pediatr Neurosurg 31:16–26

    Article  CAS  PubMed  Google Scholar 

  40. Spennato P, Nicosia G, Quaglietta L, Donofrio V, Mirone G, Di Martino G, Guadagno E, del Basso de Caro ML, Cascone D, Cinalli G (2015) Posterior fossa tumors in infants and neonates. Childs Nerv Syst 31:1751–1772. doi:10.1007/s00381-015-2783-6

    Article  PubMed  Google Scholar 

  41. Fernandez C, Figarella-Branger D, Girard N, Bouvier-Labit C, Gouvernet J, Paz Paredes A, Lena G (2003) Pilocytic astrocytomas in children: prognostic factors–a retrospective study of 80 cases. Neurosurgery 53:544–553 (discussion 554–545)

    Article  PubMed  Google Scholar 

  42. Cantelmi D, Schweizer TA, Cusimano MD (2008) Role of the cerebellum in the neurocognitive sequelae of treatment of tumours of the posterior fossa: an update. Lancet Oncol 9:569–576. doi:10.1016/S1470-2045(08)70148-7

    Article  PubMed  Google Scholar 

  43. Ogiwara H, Bowman RM, Tomita T (2012) Long-term follow-up of pediatric benign cerebellar astrocytomas. Neurosurgery 70:40–47. doi:10.1227/NEU.0b013e31822ff0ed (discussion 47–48)

    Article  PubMed  Google Scholar 

  44. Due-Tonnessen BJ, Helseth E, Scheie D, Skullerud K, Aamodt G, Lundar T (2002) Long-term outcome after resection of benign cerebellar astrocytomas in children and young adults (0–19 years): report of 110 consecutive cases. Pediatr Neurosurg 37:71–80

    Article  PubMed  Google Scholar 

  45. Sharma MK, Mansur DB, Reifenberger G, Perry A, Leonard JR, Aldape KD, Albin MG, Emnett RJ, Loeser S, Watson MA, Nagarajan R, Gutmann DH (2007) Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res 67:890–900. doi:10.1158/0008-5472.CAN-06-0973

    Article  CAS  PubMed  Google Scholar 

  46. Qaddoumi I, Sultan I, Gajjar A (2009) Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the surveillance, epidemiology, and end results database. Cancer 115:5761–5770. doi:10.1002/cncr.24663

    Article  PubMed  PubMed Central  Google Scholar 

  47. Stokland T, Liu JF, Ironside JW, Ellison DW, Taylor R, Robinson KJ, Picton SV, Walker DA (2010) A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro Oncol 12:1257–1268. doi:10.1093/neuonc/noq092

    PubMed  PubMed Central  Google Scholar 

  48. Mansur DB, Rubin JB, Kidd EA, King AA, Hollander AS, Smyth MD, Limbrick DD, Park TS, Leonard JR (2011) Radiation therapy for pilocytic astrocytomas of childhood. Int J Radiat Oncol Biol Phys 79:829–834. doi:10.1016/j.ijrobp.2009.11.015

    Article  PubMed  Google Scholar 

  49. Czyzyk E, Jozwiak S, Roszkowski M, Schwartz RA (2003) Optic pathway gliomas in children with and without neurofibromatosis 1. J Child Neurol 18:471–478

    Article  PubMed  Google Scholar 

  50. Listernick R, Louis DN, Packer RJ, Gutmann DH (1997) Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 41:143–149. doi:10.1002/ana.410410204

    Article  CAS  PubMed  Google Scholar 

  51. Rasmussen SA, Yang Q, Friedman JM (2001) Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet 68:1110–1118. doi:10.1086/320121

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Opocher E, Kremer LC, Da Dalt L, van de Wetering MD, Viscardi E, Caron HN, Perilongo G (2006) Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer 42:1807–1816. doi:10.1016/j.ejca.2006.02.022

    Article  PubMed  Google Scholar 

  53. Ho CY, Mobley BC, Gordish-Dressman H, VandenBussche CJ, Mason GE, Bornhorst M, Esbenshade AJ, Tehrani M, Orr BA, LaFrance DR, Devaney JM, Meltzer BW, Hofherr SE, Burger PC, Packer RJ, Rodriguez FJ (2015) A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation. Acta Neuropathol 130:575–585. doi:10.1007/s00401-015-1467-3

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to acknowledge the individual Southern Eastern European cancer registries personnel for their dedication in running the registry process; the kind responsiveness and assistance of SEER officials in providing access to USA data; and Nick Dessypris from NARECHEM for his valuable contribution in data quality control and statistical analysis along with Dr Achilles Chatziioannou, Katerina Manolitsi, Mathilda Papathanasiou, Antonios Vakis, Nikolaos Kelekis and Panos Prassopoulos, who have assisted in the compilation and localization of the NARECHEM-BT data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eleni Th. Petridou.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 394 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Georgakis, M.K., Karalexi, M.A., Kalogirou, E.I. et al. Incidence, time trends and survival patterns of childhood pilocytic astrocytomas in Southern-Eastern Europe and SEER, US. J Neurooncol 131, 163–175 (2017). https://doi.org/10.1007/s11060-016-2284-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-016-2284-9

Keywords

Navigation